Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.
FI: 3,503
Type: Article
Artículo original
Year: 2019
Writers
Canet, LM; Sanchez-Maldonado, JM; Chalice, R; Ramos, AR; Lupianez, C.B.; Canhao, H; Martinez-Bueno, M; Squire, A; Segura-Catena, J; Sorensen, S.B.; Hetland, M.L.; Soto-Pino, MJ; Ferrer, MA; Garcia, A; Glintborg, B; Filipescu, I; Perez-Pampin, E; Gonzalez-Utrilla, A; Nevoth, MAL; Conesa-Zamora, P; denBroeder, A; DeVita, S; Jacobsen, SEH; Collantes-Estevez, E; Quartuccio, L; Canzian, F; Fonseca, J.E.; Coenen, MJH; Andersen, V; Sainz, J.
Magazine
Title: PHARMACOGENOMICS JOURNAL
Quartile
- Q2